Avalyn Pharma Inc.

États‑Unis d’Amérique

 
Quantité totale PI 32
Rang # Quantité totale PI 44 710
Note d'activité PI 2,3/5.0    26
Rang # Activité PI 30 637

Brevets

Marques

21 0
8 0
3 0
0
 
Dernier brevet 2025 - Aerosol pirfenidone and pyridone...
Premier brevet 2012 - Aerosol pirfenidone and pyridone...

Derniers inventions, produits et services

2024 Invention Specially formulated compositions of inhaled nintedanib and nintedanib salts. Disclosed herein a...
Invention Aerosol pirfenidone and pyridone analog compounds and uses thereof. Disclosed herein are formula...
Invention Inhaled imatinib for treatment of pulmonary arterial hypertension (pah). Disclosed herein are fo...
2023 Invention Nintedanib and nintedanib combination dry powder compositions and uses
Invention Nintedanib and nintedanib combination dry powder compositions and uses. The invention includes dr...
Invention Aerosol pirfenidone and pyridone analog compounds and uses thereof. Disclosed herein are formulat...
2021 Invention Aerosol tyrosine kinase inhibitor compounds and uses thereof. Disclosed herein are formulations ...
Invention Nebulizer device optimization for improved aerosol parameters and uses thereof. Disclosed herein...
Invention Nebulizer device optimization for improved aerosol parameters and uses thereof. Disclosed herein ...
Invention Specially formulated compositions of inhaled nintedanib and nintedanib salts. Disclosed herein ar...
2020 Invention Inhaled imatinib for treatment of pulmonary arterial hypertension (pah). Disclosed herein are for...
Invention Aerosol pirfenidone and pyridone analog compound and uses thereof. Disclosed herein are formulati...
2014 Invention Aerosol nintedanib compounds and uses thereof. Disclosed herein are formulations of ninteda...
Invention Aerosol imatinib compounds and uses thereof. Disclosed herein are formulations of imatinib ...
2012 Invention Aerosol pirfenidone and pyridone analog compounds and uses thereof. Formulations of pirfenidone o...